Morphogenesis, Inc Raises $16 Million to Advance into Human Clinical Trials
TAMPA, Fla. – (May 2, 2018) – Morphogenesis, Inc., a Tampa, FL-based immunotherapy company closed a $16 million Series A
TAMPA, Fla. – (May 2, 2018) – Morphogenesis, Inc., a Tampa, FL-based immunotherapy company closed a $16 million Series A
Copyright © 2024 Skyway Capital Markets | Skyway Capital Markets, LLC is a member FINRA/SIPC.